Grameva Limited Intrinsic Value
GRAMEVA · Commodities · Current price ₹95
Is Grameva Limited undervalued?
DocStoX estimates the fair value of Grameva Limited at ₹97 per share, versus the current market price of ₹95. That puts the stock about +2.2% below our fair-value estimate, which we read as "Expensive". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹41), Relative P/E (₹244), Graham floor (₹58). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹41 (bear) to ₹97 (base) to ₹244 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Margin of safety
Value investors demand a margin of safety — a discount to intrinsic value that protects against being wrong. At ₹95 versus an intrinsic value of ₹97, Grameva Limited currently offers +2.2% of margin.
More on Grameva Limited
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.